お知らせ • Sep 25
Range Impact, Inc. announced that it has received $0.55 million in funding from Tower Iv LLC Range Impact, Inc. entered into securities purchase agreements with Edward Feighan, the Chairman of the Board of Directors of the Company, Michael Cavanaugh, a director and Chief Executive Officer of the Company, and Tower IV, LLC, an existing shareholder of the Company on September 23, 2025. The company has issued 3,666,667 shares at a price of $0.15 per share for gross proceeds $550,000.05. Messrs. Feighan and Cavanaugh each invested $100,000 in the Shares and Tower IV, LLC invested $350,000. The transaction was closed on September 23, 2025. お知らせ • Oct 03
Placer Biosciences, Inc. acquired Graphium Biosciences, Inc. from Range Impact, Inc. (OTCPK:RNGE). Placer Biosciences, Inc. acquired Graphium Biosciences, Inc. from Range Impact, Inc. (OTCPK:RNGE) on September 30, 2024. A cash consideration will be paid by Placer Biosciences, Inc. As part of consideration, an undisclosed value is paid towards None of Graphium Biosciences, Inc. The consideration consists of (i) a warrant exchangeable into 1,000 shares of the common stock of the Purchaser, exercisable at $0.01 per share, expiring September 30, 2034, subject to certain anti-dilution adjustments; (ii) de minimis cash consideration; and (iii) 50% of any equipment sale proceeds realized by Purchaser during the 12-month period following the closing. The Stock Purchase Agreement contains terms, conditions, covenants, indemnification provisions, and representations and warranties from each of the respective parties that are customary and typical for a transaction of this nature. After a close review and examination of the status of both corporate strategies and the current market environment, the Company’s Board of Directors determined that it is in the shareholders’ best interests to separate these two distinct businesses by divesting Graphium.
UB Greensfelder LLP acted as legal advisor to Range. Thompson Coburn LLP acted as legal advisor to Placer.
Placer Biosciences, Inc. completed the acquisition of Graphium Biosciences, Inc. from Range Impact, Inc. (OTCPK:RNGE) on September 30, 2024. お知らせ • Jun 21
Continental Heritage Holding Company, Llc acquired an unknown minority stake in Range Impact, Inc. (OTCPK:RNGE) for $1 million. Continental Heritage Holding Company, Llc acquired an unknown minority stake in Range Impact, Inc. (OTCPK:RNGE) for $1 million on June 17, 2024. A cash consideration valued at $0.27 per share will be paid by Continental Heritage Holding Company, Llc for the acquisition of 3,703,704 shares of the Company’s common stock.
Continental Heritage Holding Company, Llc completed the acquisition of an unknown minority stake in Range Impact, Inc. (OTCPK:RNGE) on June 17, 2024. お知らせ • Dec 22
Range Impact, Inc. announced that it has received $1.7 million in funding Range Impact, Inc. announced that it has entered into securities purchase agreements with each of the purchasers to issue 11,333,336 shares at an issue price of $0.15 per share for the gross proceeds of $1,700,000.4 on December 21, 2023. The sale of the Shares was exempt from the registration requirements of the Securities Act as transactions by an issuer not involved in any public offering under Section 4(a)(2) of the Securities Act and Rule 506 of Regulation D promulgated under the Securities Act (“Regulation D”). The Company made this determination based on the representations of the Purchasers in the Purchase Agreements, including, but not limited to, that each of them is an “accredited investor” within the meaning of Rule 501 of Regulation D and each of them had access to full and complete information about the Company and its investment. お知らせ • Sep 07
Malachite Innovations, Inc. (OTCPK:MLCT) acquired Collins Building & Contracting, Inc. from Roger L. Collins, Jr. for $5.035 million. Malachite Innovations, Inc. (OTCPK:MLCT) acquired Collins Building & Contracting, Inc. from Roger L. Collins, Jr. for $5.035 million on August 31, 2023. The consideration comprised of $1.0 million of cash, a $2.0 million seller note collateralized by the acquired real estate and quarry infrastructure, and a separate $2.035 million seller note collateralized by the acquired equipment. Roger Collins will serve as Senior Vice President of Sales of Range Environmental Resources, Inc., a wholly-owned subsidiary of Malachite. Howard Groedel of Ulmer & Berne acted as legal advisor to Malachite Innovations, Inc. Thomas Spears of Daniels Law Firm, PLLC acted as legal advisor to Roger L. Collins, Jr.
Malachite Innovations, Inc. (OTCPK:MLCT) acquired Collins Building & Contracting, Inc. on August 31, 2023. お知らせ • Aug 17
Malachite Innovations, Inc. announced delayed 10-Q filing On 08/16/2022, Malachite Innovations, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC. お知らせ • Aug 21
Vitality Biopharma, Inc. announced that it expects to receive $5 million in funding Vitality Biopharma, Inc. announced that it has entered into a securities purchase agreement with a institutional investor for private placement of common shares for gross proceeds of up to $5,000,000 on August 19, 2021. The company will issue shares in tranches of up to $250,000 until the financing arrangement expires on December 31, 2022. The share price is equal to 85% of the lowest daily volume weighted average price during the 5 trading days prior the 3rd business day following its submission of the purchase notice. The company will also issue warrants at a price equal to 115% of the lowest daily volume weighted average price expires on the five-year anniversary of the date of issuance. お知らせ • Sep 26
Vitality Biopharma, Inc. Elects Brandon Zipp as Chief Science Officer On September 24, 2020, the Board of Directors of Vitality Biopharma, Inc. elected Dr. Brandon Zipp as Chief Science Officer.